Player FM ऐप के साथ ऑफ़लाइन जाएं!
#15 Safety of HIV medications – Henry Zakumumpa
Manage episode 424661253 series 2749727
With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects. Henry Zakumumpa from Makerere University School of Public Health tells us about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda.
Tune in to find out:
- How dolutegravir-based HIV therapies compare to earlier regimens
- How pharmacovigilance data can help shape HIV treatment guidelines
- Why we should empower patients to share concerns about their healthcare
Want to know more?
Hyperglycemia, insomnia and reduced libido were the most common side effects observed by Ugandan clinicians in patients taking dolutegravir.
Nurses are the backbone of HIV disease management in Uganda and could play an important role in pharmacovigilance activities as well.
Henry Zakumumpa’s research was supported by Uppsala Monitoring Centre in collaboration with CARTA, the Consortium for Advanced Research Training in Africa, which is working to build up research capacity in public health.
The World Health Organization’s resources on HIV/AIDS include easily digestible information for patients, epidemiological data on disease spread, and current guidelines for prevention and treatment.
For more on African and patient-centred pharmacovigilance, check out these episodes from the Drug Safety Matters archive:
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
52 एपिसोडस
Manage episode 424661253 series 2749727
With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects. Henry Zakumumpa from Makerere University School of Public Health tells us about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda.
Tune in to find out:
- How dolutegravir-based HIV therapies compare to earlier regimens
- How pharmacovigilance data can help shape HIV treatment guidelines
- Why we should empower patients to share concerns about their healthcare
Want to know more?
Hyperglycemia, insomnia and reduced libido were the most common side effects observed by Ugandan clinicians in patients taking dolutegravir.
Nurses are the backbone of HIV disease management in Uganda and could play an important role in pharmacovigilance activities as well.
Henry Zakumumpa’s research was supported by Uppsala Monitoring Centre in collaboration with CARTA, the Consortium for Advanced Research Training in Africa, which is working to build up research capacity in public health.
The World Health Organization’s resources on HIV/AIDS include easily digestible information for patients, epidemiological data on disease spread, and current guidelines for prevention and treatment.
For more on African and patient-centred pharmacovigilance, check out these episodes from the Drug Safety Matters archive:
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
52 एपिसोडस
सभी एपिसोड
×![Artwork](/static/images/128pixel.png)
1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
![Artwork](/static/images/128pixel.png)
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
![Artwork](/static/images/128pixel.png)
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
![Artwork](/static/images/128pixel.png)
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
![Artwork](/static/images/128pixel.png)
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
![Artwork](/static/images/128pixel.png)
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
![Artwork](/static/images/128pixel.png)
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
![Artwork](/static/images/128pixel.png)
1 #28 Catching black swans – François Montastruc 27:21
![Artwork](/static/images/128pixel.png)
1 #27 When drugs damage the liver – Rita Baião 28:30
![Artwork](/static/images/128pixel.png)
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
![Artwork](/static/images/128pixel.png)
1 #25 A week in the name of medicines safety – part 2 33:13
![Artwork](/static/images/128pixel.png)
1 #24 A week in the name of medicines safety – part 1 27:09
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – The colour of signals 33:59
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।